臺灣博碩士論文加值系統

第一章 緒論...............................................................1
第一節 研究背景與重要性....................................................1
第二節 研究目的...........................................................2
第三節 研究問題...........................................................3
第四節 研究假設...........................................................4
第五節 名詞解釋...........................................................5
第二章 文獻查證...........................................................6
第一節 膀胱癌.............................................................6
第二節 癌症病人拒絕治療概況.................................................9
第三節 癌症病人中斷治療概況................................................10
第四節 癌症病人拒絕治療之相關因素...........................................11
第五節 癌症病人中斷治療之相關因素...........................................12
第三章 研究方法...........................................................13
第一節 研究設計...........................................................13
第二節 資料庫來源及研究對象................................................14
第三節 研究架構...........................................................15
第四節 研究工具...........................................................16
第五節 研究步驟...........................................................17
第六節 倫理考量...........................................................18
第七節 資料處理與分析.....................................................19
第四章 研究結果...........................................................21
第一節 探討膀胱癌病人基本屬性及疾病屬性.....................................22
第二節 探討膀胱癌病人拒絕治療及中斷治療與基本屬性及疾病屬性之相關性.............27
第三節 探討膀胱癌病人拒絕治療及中斷治療之預測因子.............................37
第四節 探討膀胱癌病人拒絕治療及中斷治療之原因................................41
第五章 討論...............................................................45
第一節 膀胱癌病人拒絕治療率................................................46
第二節 膀胱癌病人中斷治療率................................................47
第三節 膀胱癌病人拒絕治療之相關因素.........................................48
第四節 膀胱癌病人中斷治療之相關因素.........................................49
第五節 膀胱癌病人拒絕治療及中斷治療之原因....................................50
第六章 限制與建議..........................................................51
第一節 結論..............................................................51
第二節 研究限制與建議.....................................................52
第三節 實務應用...........................................................53
參考文獻...................................................................54
中文部份..................................................................54
英文部分..................................................................56

一、中文部分
中華民國教育部(2015)．教育部重編國語辭典修訂本．取自 http://dict.revised.moe.edu.tw/cgi-bin/cbdic/gsweb.cgi?o=dcbdic&searchid=Z00000024083
王淑華、莊昭華（2018）．頭頸癌患者中斷治療危險因子文獻回顧．彰化護理．25（3），36-42。https://doi.org/10.6647/CN.201809_25(3).0007
丘周萍、張凱喬、桑穎穎（2014）．泌尿系統疾病與護理．於王桂芸總校閱，新編內外科護理下冊（五版，14-89-14-96頁）．臺北市：永大。
李嘉惠、謝珮琳、陳瑋（2018）．泌尿系統疾病之護理．於劉雪娥總校閱，成人內外科護理下冊（七版，771-878頁）．臺北市：華杏。
周淑嵐、林玉芬、林梅香、姜亭妤、王靜婷、王昭慧（2019）．個案管理過程藉由PRECEDE模式評估癌症病人中斷治療影響因素．腫瘤護理雜誌．19（1），49-63。https://doi.org/10.6880/TJON.201906_19(1).05
周淑嵐、林梅香、林玉芬、姜亭妤、王靜婷、王昭慧（2015）．個案管理過程中運用PRECEDE模式探討癌症病人中斷治療影響因素．腫瘤護理雜誌，15（1），39-46。https://doi.org/10.3966/168395442015061501005
林紋麗、張書展、吳佩樺、黃文聰、曹朝榮（2016）．胃癌病人拒絕手術的原因與存活率分析析．醫院雙月刊，49（6），1-11。
張碧容、李鳳屏、蕭華岑、謝秀芳（2017）．治療或不治～就是問題所在：老年癌症病人照護的倫理議題．腫瘤護理雜誌．15（2），1-18。https://doi.org/10.3966/168395442015121502001
陳玉萍、曾雁明、曾振淦、洪志宏（1997）．鼻咽癌病人放射治療中斷的原因及分析．放射治療與腫瘤學．4（2），251-257。https://doi.org/10.6316/TRO/199704(4)251
陳美君、陳宛榆、崔宛玉、張桂玲、洪敏瑛（2018）．整合跨團隊資源之個案管理照護方案提升癌症病人重返治療率之改善專案．護理雜誌．65（2），75-84。https://doi.org/10.6224/JN.201804_65(2).10
楊佩瑄、林美瑩、羅珮娟、林貴香、黃綉雲（2017）．口腔癌病人接受腫瘤個案管理照護之未完成治療原因及存活分析．腫瘤護理雜誌．17(1)，31-48。https://doi.org/10.3966/168395442017061701004
蔡麗紅（1999）．膀胱腫瘤之外科治療及護理．護理雜誌，46（1），65-70。https://doi.org/10.6224/JN.46.1.65
衛生福利部國民健康署（2018，12月）．中華民國105年癌症登記報告．取自 https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269&pid=10227
衛生福利部國民健康署（2018，7月）．早期癌症五年存活率可達八成以上罹癌並不可怕 延誤診治才是真正殺手．取自 https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1135&pid=2951
衛生福利部統計處（2018，11月）．106年主要死因統計結果分析．取自https://dep.mohw.gov.tw/DOS/cp-3960-41756-113.html
衛生福利部統計處（2018，12月）．106年度全民健康保險醫療統計年報．取自https://dep.mohw.gov.tw/DOS/cp-4268-45882-113.html
三、英文部分
Arcangeli, G., Strigari, L., & Arcangeli, S. (2015). Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials. Critical Reviews in Oncology Hematology, 95(3), 387-396. https://doi.org/10.1016 /j.critrevonc.2015.04.006
Chang, Y. L., Lee, S.C., Liao, C. T., Wang, C. H., Lin, Y.F., & Chen, S. C. (2019). Factors impacting on discordance with treatment plan in head and neck cancer patients: A retrospective, population-based cohort study. Supportive Care in Cancer, 28(2), 951-958.https://doi.org/10.1007/s00520-019-04904-z
Chen, S. J., Kung, P. T., Huang, K. H., Wang, Y. H., & Tsai, W. C. (2015). Characteristics of the delayed or refusal therapy in breast cancer patients: A longitudinal population-based study in Taiwan. PLoS ONE, 10(6), e0131305. https://doi.org/10.1371/journal.pone.0131305.
Chiang, T. Y., Wang, C. H., Lin, Y. F., You J.F., Chen, J.S., & Chen, S. C. (2018). Colorectal cancer in Taiwan: A case‐control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment. Journal of Advanced Nursing, 74(2), 305-402. https://doi.org/10.1111/jan.13443
Danna, B. J., Metcalfe, M. J., Wood, E. L., & Shah, J.B. (2016). Assessing symptom burden in bladder cancer: An overview of bladder cancer specific health-related quality of life instruments. Bladder Cancer, 2(2), 329-340. https://doi.org/10.3233/BLC-160057
DeGeorge, K. C., Holt, H.R., & Hodges, S.C. (2017). Bladder cancer: Diagnosis and treatment. American Family Physician, 96(8), 507-514.
Freedman R.A., Fedewa S.A., Punglia R.S., Lin C.C., Ward E.M., Jemal A., & Sineshaw H.M. (2016). Factors associated with radiation therapy incompletion for patients with early-stage breast cancer. Breast Cancer Research and Treatment, 155(1), 187–199. https://doi.org/10.1007/s10549-015-3660-4
Helena M. V., Gerald M.F., Elisabetta R., Herve B., Georges V., John K., Peter S., Andre-Pascal S., Hyma S., & Christine B. (2005). Patients’ refusal of surgery strongly impairs breast cancer survival. Annals of Surgery, 242, 276-280. https://doi.org/10.1097/01.sla.0000171305.31703.84
Jacob L., Hadji P., Albert U.S., Kalder M., & Kostev K. (2015). Impact of disease management programs on women with breast cancer in Germany. Breast Cancer Research and Treatment, 153(2), 391–395. https://doi.org/ 10.1007/s10549-015-3530-0
Kemp, A., Preen, D.B., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., & Roughead, E.E. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? SpringerPlus, 3, 282. https://doi.org/10.1186/2193-1801-3-282. eCollection 2014
Maddocks K.J., Ruppert A.S., Lozanski G., Heerema N.A., Zhao W., Abruzzo L., Lozanski A., ….. & Woyach J.A. (2015). Etiology of Ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncology, 1(1), 80–87. https://doi.org/10.1001/jamaoncol.2014.218.
Martinez Rodriguez, R, H., Buisan Rueda, O., & Ibarz, L. (2017). Bladder cancer: Present and future. Medicina Clinica, 10, 449-455. https://doi.org/ 10.1016/j.medcli.2017.06.009.
Mehta, R.S., Lenzner, D., & Argiris, A. (2012). Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: A SEER cohort study. Annal of Surgery Oncology, 19(3), 722–727. https://doi.org/ 10.1245/s10434-011-2087-3
National Institute for Health and Care Excellence. (2017). Bladder cancer: Diagnosis and management. British Journal of Urology, 120(6), 755-765. https://doi.org/ 10.1111/bju.14045.
Rutherford, C., Costa, D.S.J., King, M.T., Smith, D.P., & Patel, M.I.(2017). A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer. Supportive Care in Cancer, 25(10), 3095-3102. https://doi.org/ 10.1007/s00520-017-3717-5
Shayeb, M. E., Scarfe, A., Yasui, Y., & Winget, M. (2012). Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: A population based chart review. BMC Research Notes, 269(5), 1-8. https://doi.org/10.1186/1756-0500-5-269
Wallace, S. K., Lin, J. F., Cliby, W. A., Leiserowitz, G. S., Tergas, A. I., & Bristow, R. E. (2016). Refusal of recommended chemotherapy for ovarian cancer: Risk factors and outcomes: A national cancer data base study. Journal of the National Comprehensive Cancer Network, 14(5), 539-50. https://doi.org/ 10.6004/jnccn.2016.0062
Woldu, S. L., Bagrodia, A., & Lotan, Y. (2017). Guideline of Guidelines – Non-Muscle Invasive Bladder Cancer. BJU International Journal, 119(3), 371-380. https://doi.org/10.1111/bju.13760
World Health Organization (WHO). (2018). Cancer. Retrieved from http://www.who.int/zh/news-room/fact-sheets/detail/cancer
World Health Organization (WHO). (2019). Cancer. Retrieved from https://www.who.int/cancer/en/
World Health Organization (WHO). (2010). National Comprehensive Cancer Network (NCCN) (2018) NCCN guidelines for treatment of cancer by site—bladder cancers treatment. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx